A microbial byproduct of intestinal bacteria contributes to heart disease and serves as an accurate screening tool for predicting future risks of heart attack, stroke and death in persons not otherwise identified by traditional risk factors and blood tests, according to Cleveland Clinic research published today in The New England Journal of Medicine.
Fuente : http://www.eurekalert.org/pub_releases/2013-04/cc-...
Fuente : http://www.eurekalert.org/pub_releases/2013-04/cc-...